Cisplatin concurrent chemoradiotherapy vs adjuvant radiation in stage IB/IIA cervical cancer with intermediate risk factors, treated with radical surgery: a retrospective study

PURPOSE: To determine if postoperative cisplatin concurrent chemoradiotherapy (CCRT) improves the outcome in stage IA/IIB cervical cancer patients with intermediate risk factors, when compared with radiation therapy (RT) alone, and identify the potential eligible populations for this treatment. PATI...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Hai-Yan, Tang, Qiu, Chen, Jian-Hong, Lv, Xiao-Juan, Tu, Ye-Qiang, Yan, Ding-Ding
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846308/
https://www.ncbi.nlm.nih.gov/pubmed/29563803
http://dx.doi.org/10.2147/OTT.S158214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846308/
https://www.ncbi.nlm.nih.gov/pubmed/29563803
http://dx.doi.org/10.2147/OTT.S158214

Ejemplares similares